Sales rise 63.99% to Rs 10.20 crore
Net loss of Genpharmasec reported to Rs 0.13 crore in the quarter ended March 2024 as against net profit of Rs 1.05 crore during the previous quarter ended March 2023. Sales rose 63.99% to Rs 10.20 crore in the quarter ended March 2024 as against Rs 6.22 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 0.13 crore in the year ended March 2024 as against net profit of Rs 1.12 crore during the previous year ended March 2023. Sales rose 19.16% to Rs 30.41 crore in the year ended March 2024 as against Rs 25.52 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales10.206.22 64 30.4125.52 19 OPM %-0.103.22 -0.131.02 - PBDT0.140.21 -33 0.290.30 -3 PBT0.110.20 -45 0.250.28 -11 NP-0.131.05 PL -0.131.12 PL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
